Advanced search
Publication Cover
Journal of Addictive Diseases Volume 31, 2012 - Issue 2
Submit an article Journal homepage
362
Views
7
CrossRef citations to date
0
Altmetric
ARTICLES

Clinical Differences Between Opioid Abuse Classes Ameliorated After 1 Year of Buprenorphine-Medication Assisted Treatment

Joseph Tkacz MS Health Analytics, LLC, Columbia, Maryland, USA
,
Jamie Severt BA Health Analytics, LLC, Columbia, Maryland, USA
,
Cheryl Kassed PhD Health Analytics, LLC, Columbia, Maryland, USA
&
Charles Ruetsch PhD Health Analytics, LLC, Columbia, Maryland, USA
Pages 100-111 | Published online: 27 Apr 2012
 
Sample our Behavioral Sciences journals, sign in here to start your access, latest two full volumes FREE to you for 14 days

Abstract

This study compared the clinical and demographic profiles of three opioid-dependent user groups, and measured their response to 1 year of buprenorphine-medication assisted treatment. Opioid prescription, street, and combination (street + prescription) users completed the Addiction Severity Index multiple times over the course of one treatment year. Although groups differed on all measured demographics (P values <.05) and on six of seven Addiction Severity Index composite scores at induction (P values <.05), differences were ameliorated after 1 year. Findings highlight the disparities between the various opioid-dependent patient subpopulations and suggest that buprenorphine-medication assisted treatment is an effective treatment across user subtypes.

Acknowledgments

Part of this work was funded by a research grant from Reckitt Benckiser Pharmaceuticals, Inc.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Stigma, social inequality and alcohol and drug use
Source: Wiley
Truth or consequences: the validity of self-report data in health services research on addictions.
Source: Wiley
Reliability and validity of the addiction severity index with a homeless sample
Source: Elsevier BV
Validation of the Addiction Severity Index (ASI) for internet and automated telephone self-report administration.
Source: Elsevier BV
Is the Addiction Severity Index a Reliable and Valid Assessment Instrument Among Clients with Severe and Persistent Mental Illness and Substance Abuse Disorders
Source: Springer Science and Business Media LLC
Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
Source: Elsevier BV
Opioid Relapse
Source: Wiley
Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States
Source: Oxford University Press (OUP)
Opioid prescriptions soar: increase in legitimate use as well as abuse.
Source: American Medical Association (AMA)
Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients
Source: Springer Science and Business Media LLC
Characterizing the Emerging Population of Prescription Opioid Abusers
Source: Wiley
Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.
Source: eScholarship, University of California
A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: Study feasibility and sample description
Source: Elsevier BV
The fifth edition of the addiction severity index
Source: Elsevier BV
Consensus statement on office-based treatment of opioid dependence using buprenorphine
Source: Elsevier BV
Health warnings for people who use heroin
Source: Elsevier BV
Characterizing the “Awakening Elephant” of Prescription Opioid Misuse in North America: Epidemiology, Harms, Interventions
Source: SAGE Publications
Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients
Source: Elsevier BV
The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System.
Source: Wiley
College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement
Source: Elsevier BV
Growing Internet Use May Help Explain The Rise In Prescription Drug Abuse In The United States
Source: Health Affairs (Project Hope)
How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Source: Ovid Technologies (Wolters Kluwer Health)
Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users.
Source: Wiley
Characteristics and consequences of heroin use among older adults in the United States: a review of the literature, treatment implications, and recommendations for further research.
Source: Elsevier BV
A Ten-Year Perspective
Source: American Medical Association (AMA)

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.